The BalancedInvestor Club

WST Market Analysis

Overview

Fundamentals

P/E ratio40.14Forward 34.97
EPS (TTM)$7.4956.1% YoY
Profit margin16.9%HEALTHCARE
Market cap$21.24BLarge cap

Wall Street coverage

$349.85median target· current $366.54 (-4.6%)15 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
34.97
PEG ratio
2.89
P/B
7.10
P/S (TTM)
6.59
EV/EBITDA
24.78

Profitability & growth

ROE (TTM)
19.1%
Operating margin
21.7%
Revenue growth YoY
21.0%
Dividend yield
0.3%
Beta
1.15
Last earnings
Apr 23, 2026 · Estimate $1.68 · Reported $2.13
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Classification

Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
530 HERMAN O. WEST DRIVE, EXTON, PA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$21.24B
Shares outstanding$70.6M
52W high$321.55
52W low$202.12

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer